Welcome
Support Centre
06 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The Warwick Arthroplasty Trial
ISRCTN ISRCTN33354155
ClinicalTrials.gov identifier
Public title The Warwick Arthroplasty Trial
Scientific title The Warwick Arthroplasty Trial: a randomised controlled trial of total hip arthroplasty versus resurfacing hip arthroplasty in the treatment of young patients with arthritis of the hip joint
Acronym WAT
Serial number at source Protocol version 2
Study hypothesis There is no difference in hip function in patients with severe arthritis of the hip joint who have undergone a total hip arthroplasty or a resurfacing arthroplasty at one year post-operation.
Ethics approval Approval received from the Coventry Research Ethics Committee on the 9th May 2007 (ref: 07/Q2802/26).
Study design Randomised single blind controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Osteoarthritis of the hip joint
Participants - inclusion criteria 1. Over the age of 18
2. Able to give informed consent
3. Eligible for hip resurfacing arthroplasty
Participants - exclusion criteria Patients with a concomitant medical problem that will preclude operation.
Anticipated start date 01/06/2007
Anticipated end date 31/05/2010
Status of trial Ongoing
Patient information material
Target number of participants 172
Interventions 1. Patients in the Total Hip Arthroplasty group will have the head of their femur removed and replaced with a prosthetic component fixed inside the femoral shaft
2. Patients in the Hip Resurfacing Arthroplasty group will have a resurfacing ‘cap’ placed upon their existing femoral head

Both groups will have a new acetabular (socket) component. The details of both operative procedures will be left to the discretion of the surgeon to increase generalisabilty of the result. All patients will receive standardised rehabilitation after the operation. As part of the research patients will be followed-up for one year post-operation.

Joint sponsor of this trial:
University of Warwick (UK)
c/o Donna McIntyre, Grants and Contracts Officer
Research Support Services
University House, Kirby Corner Road
Coventry CV4 8UW
United Kingdom
Tel: +44 (0)2476 522989
Email: D.McIntyre@warwick.ac.uk
Primary outcome measure(s) 1. Harris Hip Score, measured at pre-operation and 6, 12, 26 and 52 weeks post-operation
2. Oxford Hip Score, measured at pre-operation and 6, 12, 26 and 52 weeks post-operation
Secondary outcome measure(s) All secondary outcomes will be measured at pre-operation and 6, 12, 26 and 52 weeks post-operation:
1. Disability Rating Index
2. Physical activity level
3. Complication rate
4. Quality of life
5. Health economic evaluation
Sources of funding National Institute of Health Research (UK) - under the Research for Patient Benefit scheme (ref number: PB-PG-0706-10080)
Trial website
Publications
Contact name Mr  Matthew  Costa
  Address Associate Professor Trauma and Orthopaedics Warwick Medical School
Clinical Sciences Research Institute
Clifford Bridge Road
  City/town Coventry
  Zip/Postcode CV2 2DX
  Country United Kingdom
  Tel +44 (0)2476 968618
  Fax +44 (0) 2476 968617
  Email Matthew.Costa@warwick.ac.uk
Sponsor University Hospitals Coventry and Warwickshire NHS Trust (UK)
  Address c/o Ceri Jones
Research and Development Department
Clifford Bridge Road
  City/town Coventry
  Zip/Postcode CV2 2DX
  Country United Kingdom
  Tel +44 (0)2476 966196
  Email Ceri.jones@UHCW.nhs.uk
  Sponsor website: http://www.uhcw.nhs.uk/
Date applied 28/06/2007
Last edited 21/07/2008
Date ISRCTN assigned 17/09/2007
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central